Introduction
Neuroendocrine control systems respond rapidly to physiological challenges while concurrently undergoing adaptation on a much slower time scales (e.g. Schmidt and Thews, 1989; Frayn, 2003) . Moreover, an interplay prevails between processes at disparate scales: the slow adaptation is a dependent on the fast events. Such an interplay is a pervasive characteristic of many biological systems. Table 1 for an explanation of the symbols.
As is well known, the dynamics of such systems can be analysed by considering separate and distinct dynamical systems that correspond to the biological system as it operates on two or more "time scales". In such procedures, the approximation usually is exact if the slower component is "infinitely slower" than the faster component (see e.g. Keener and Sneyd, 1998 , for examples and applications). On a given time scale, the slower variables are "frozen" and figure as constant parameters, whereas the faster ones can often be treated using a quasi-steady state approximation (up to boundary or transition layers) in which the fast variable is essentially replaced by a function which relates its (fast-time system) equilibrium value to the prevailing values of the slower variables. Similarly, in those cases where the fast-time system does not equilibrate but tends to a periodic solution (e.g., a limit cycle or the stationary response to periodic forcing), intuition would suggest that the fast variables might be replaced by a long-term average. However, this intuition need not be correct. We outline a homogenization method to tackle such problems on two time scales (see Pavliotis and Stuart, 2008 , for an introduction to homogenization techniques). The type of system we have in mind describes the dynamics of an organism's physiology (or the relevant part thereof) together with the dynamics of the (neuro)endocrine system that regulates this physiology. We apply the method to a well-established model of the regulation of glucose concentration in the blood plasma, which we extend with a slow component, viz. the dynamics of the mass of endocrine cells. A diagrammatic representation of this system is given in Figure 1 .
Introduction to the biological application. Glucose in the blood plasma provides an essential supply of immediately available energy substrate to all tissues of the body (Salway, 1999) . Adverse effects ensue when the concentration of glucose in the blood plasma becomes either very low or very high; avoidance of these effects defines a "euglycemic" range of values and, moreover, endocrine control loops operate so as to keep the blood glucose concentration in this range (Watkins, 2003) . Whenever the supply of glucose derived from dietary carbohydrate exceeds demand from the tissues, the blood glucose level rises, stimulating the secretion of the hormone insulin, which in turn stimulates the disposition of glucose, either to be taken up as energy substrate rather than fatty acids, or to be stored away as a storage polymer, which is glycogen in liver, muscle, and kidneys, and lipid in adipose tissue (Frayn, 2003) . When energy demand outstrips supply, the blood glucose level drops and insulin is not secreted. The resulting drop in the insulin concentration leads to a decrease of insulin-dependent uptake of glucose from the bloodstream as well as an increase of the release of storage-derived glucose from the liver, both of which have the effect of restoring glucose levels. At low levels of glucose, the hormone glucagon is released, which promotes the breakdown of glycogen and fatty acids (Brook and Marshall, 2001) . A paracrine interaction between insulin and glucagon secretion has been proposed (Hope et al., 2004) . However, inasmuch as glucagon plays a prominent role in humans only when glucose falls significantly below the euglycemic range (Raju and Cryer, 2005) , the focus here is on the glucose-insulin feedback loop.
Insulin is a peptide hormone, consisting of two peptide chains linked by disulphide bonds, and produced by the β-cells in the so-called Islets of Langerhans, which are clusters of endocrine cells found scattered throughout the predominantly exocrine pancreas (Brook and Marshall, 2001 ). The total mass of β-cells changes over time: it continues to do so during adult life and it has become apparent during the past decade that the pathogenesis of both type 1 and type 2 diabetes involves failure to maintain an appropriate β-cell mass (Bonner-Weir, 2000; De León et al., 2003; Lee et al., 2006; Steil et al., 2001) . The total mass is the combined result of three processes: proliferation (cell division), apoptosis (programmed cell death), and neogenesis (regeneration from a pool of rapidly dividing cells, which themselves derive from pluripotent stem cells, or possibly de-differentiated β-cells, or alternatively trans-differentiated pancreatic cells); these processes are influenced by the levels of both glucose and insulin (Beith et al., 1998; Bouwens and Rooman, 2005; Dor et al., 2004; Efanova et al., 1998; Johnson and Alejandro, 2008; Lipsett and Finegood, 2002; Rooman et al., 2002; Young et al., 2008) . As a result, there is an interplay between the fast, ultradian fluctuations of glucose and insulin and the slower (>days) changes in β-cell mass. This means that we need to consider a fairly realistic, high-dimensional mathematical model on the fast time scale in order to abstract the slow-time dynamics; we choose the model developed by the Lyngby group (see Pattaranit and Van den Berg, 2008 , for a review of several comparable models).
Theory: time-scale homogenization
The dynamics of a system comprising both the regulated physiology and the associated (neuro)endocrine system can, in many cases, be represented as a dynamical system of the following form:
where x is the state of the system, u represents an external input, and f is the system's dynamics. We assume that the state variables in x and the input variables in u have been non-dimensionalised, so that time t is the only unit-bearing quantity remaining. The input u(t) is assumed to be a periodic function of time with period T . We now outline a construction that decomposes the original dynamics into two uncoupled systems of lower dynamical dimension. These two systems may be studied independently of one another. The idea is to preserve the way in which features of the dynamics affect the dynamics at the slow time scale, by constructing the slow dynamics as a map that is specific for the fast-scale regime. If this formulation this seems obscure: the application in Section 3 provides examples. For physiological systems it may naturally be assumed that the rates of change are bounded, that is, for each of the n state variables, there is a finite number ξ i such that the dynamics of x i satisfies
as x and u range over all physiologically attainable values. Without loss of generality, the state variables can be ordered so that
(i.e., fastest first). Scaling of the f i with respect to the corresponding ξ leads to
where ξ is a diagonal matrix with the ξ i on its main diagonal and f * i is a dimensionless quantity satisfying |f * | ≤ 1. We are interested in the case where some variables are "rapid" (i.e. oscillate on a time scale of order T ) and others are "slow". That is to say, we consider the case where
ξ n and we assume that there exists an ν ≤ n such that ξ i T is a small parameter (i.e., ξ i T 1) for ν ≤ i ≤ n. Anticipating the separation of time scales, we write
where the fast component x [0] depends on a fast time ϕ and a slow time τ , whereas the slow component x
[1] depends on slow time τ only. These two times are defined as follows:
where x denotes the largest integer smaller than or equal to x. The input is similarly decomposed;
Let us write ∂ ∂ϕ
for ϕ ∈ [0, 1). To follow the fast dynamics, equation (8) is integrated from ϕ = 0 to ϕ = 1 − subject to initial condition x [0] = 0 at ϕ = 0. Now define the following variation: for η ≤ ξ ν T and i = ν, . . . , n:
(this variation may be regarded as a total differential sensu Protter and Morrey, 1970, p. 724) . Dividing equation (9) by η and specifying for η = ξ ν T , this becomes:
for i = 1, . . . , n. In the limit ξ ν T → 0, the following expressions are exact:
where for i ≥ ν we have
i (·), and the operator ∂/∂ϕ has been replaced by d/dϕ without impunity since ϕ is restricted to the interval [0, 1). If we let x
ν+ )) is a parametrical representation of the slow manifold of the dynamics of the system (or a branch of this manifold). The fast variables x 1 , . . . , x ν−1 move close to through a forced limit cycle of period T (and exactly so in the limit ξ ν T → 0). The slow manifold can and generally will be varying in slow time τ . It may be desirable to have the slow variable represent a cycle average, rather than the start-of-cycle value which depends on the arbitrary assignment of phase value 0; this is not problematic but would render the notation somewhat more cumbersome and less perspicacious.
Calculation: application to the regulation of the glucose concentration in the blood plasma
We apply time-scale homogenization to glycemic homeostasis, which is representative of a wellstudied and important physiological system in which fast (regulatory) and slow (adaptive) responses interact in a way that is essential to the system's operation, both in health and disease.
The extended Sturis-Tolić model
The model for glucose dynamics as originally proposed by Sturis et al. (1991) and subsequently further developed by Tolić et al. (2000) is depicted diagrammatically in Figure 1 and is described 5 by the following system of ordinary differential equations:
where we have adapted the notation slightly to facilitate cross-referencing. In the model, the state variable G(t) denotes the blood plasma content of glucose whereas I p (t) denotes the blood plasma content of insulin (so that G/V g and I p /V p are plasma concentrations) and I i (t) is the amount of insulin in the interstitial spaces of the body tissues. Furthermore, w 1 (t), w 2 (t), and w 3 (t) are auxiliary state variables that mimic a delay of duration τ d in the release of glucose from hepatic glycogen stores, in response to I p (see Pattaranit and Van den Berg, 2008 , for a more detailed explanation); and Q(t) is the β-cell mass, which is a slow state variable presently added to the original model. The input is the forcing function ψ in (t), which represents the flux of glucose into the blood stream from external sources. The parameter Φ represents the diffusive exchange of insulin between blood and interstitial space; V p and V i are the distribution volumes of blood plasma and interstitial space, respectively, for insulin. The parameter τ p represents the mean life time of an insulin molecule in the blood plasma, whereas τ i represents the mean life time of an insulin molecule in the interstitial space. These dependencies are modelled in the Sturis-Tolić model by means of plausible, but empirical functional relationships, which are listed in Appendix A. As indicated in Figure 1 , there are a number of rates and fluxes that depend in various different ways on the state variables. Glucose-uptake by the tissue depends on the plasma glucose level only in the case of insulin-independent uptake (ψ ii ), but also on the plasma insulin level in the case of insulin-dependent glucose uptake (ψ id ). When glucose levels become very high, the kidneys begin to excrete glucose; this flux is indicated as ψ gx . Two fluxes contribute to increases of plasma glucose: these are the input from the food (or glucose administered by an injection or infusion), denoted as ψ in , which is treated as a forcing function in the present model, and the second flux is glucose secreted by the liver; this glucose release flux ψ gr is also dependent on both plasma glucose and plasma insulin. Glucose stimulates the secretion of insulin, and thus the insulin secretion ψ is is glucose-dependent.
The model has been extended here with the dynamics of the β-cell mass, which involves three processes: β-cell proliferation, whose specific rate ρ is assumed to depend on plasma insulin; β-cell death, occurring at a specific rate µ that depends on both plasma glucose and insulin, and a neogenesis flux ψ ng which also depends on both plasma glucose and insulin. Empirical formulas for these dependencies, as well as a justification, is given in Appendices A and B. Inasmuch as the contribution of neogenesis remains to be fully elucidated and may be considered controversial, we shall analyse the model first on the assumption that this term is absent. The glucose input ψ in (t) can assume various forms. It may be set of a constant value, as can be arranged under experimental conditions where glucose is administered by means of an infusion, or it may be time-varying. If ψ in is set to a constant value, ultradian oscillations may become prominent feature of the dynamics, as shown by Tolić et al. (2000) . Here we choose as standard reference a periodic function with a period of 24 hours and three "meal peaks" in every day, as shown in the top panel of Figure 2 . Under this particular input, the system settles on a stationary forced cycle within a few days, also shown in Figure 2. 
Analysis without neogenesis of β-cells
To analyse the dynamics in the absence of neogenesis, we set ψ ng = 0. It will emerge that the resulting β-cell dynamics is very slow on this assumption, which can be taken as indirect evidence that neogenesis is an important factor in rapid (i.e., hours/days rather than months or years) adaptation, provided we accept the parameter values taken from the literature.
Following the method outlined in Section 2, the steps are to render the system dimensionless, except for time, determine the maximum absolute rates (the ξs), and to rank the scaled variables according to these rates. Choosing 10 g as the reference value for glucose and 44 mU as the reference value for insulin, we find the following ranking (ξs all in min −1 ; Q is already dimensionless): 7 (β-cell mass)
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(∆x
7 (day A time-scale separation at ν = 7 is apparent, with small parameter ξ ν T = 8.7 × 10 −7 min −1 × (24 × 60 min) = 0.00125; a unit of slow time τ thus corresponding to 800 days.
The theory of Section 2 now prescribes that the dynamics in slow time for x [1] 7 is derived using equation 12, whereas the variables x 7 on the basis of the slow-manifold condition, which corresponds to the stationary forced cycle in fast time when x [1] 7 is held at a fixed value. These relations can be obtained numerically without trouble: results are shown in Figure 3 . Since the reference cycle corresponds to a fairly high glycemic load, higher loads may be regarded as hyperglycemic. At such loads, the dynamics of the β-cell mass has two fixed points: a lower unstable one and a higher stable point. The existence of the unstable fixed point, referred to as a "pathological fixed point" by Topp et al. (2000) , indicates that catastrophic involution of β-cell mass will occur when x 7 becomes lower than this equilibrium value. It will then decay to zero: the loss of β-cells leads to further hyperglycemia and lower insulinemia, which leads to further β-cell losses (Topp et al., 2000) . Such a process may underlie non-autoimmune diabetes mellitus, as described by Imagawa et al. (2000) . As the glycemic load increases, these two fixed points move together and collide. At even higher glycemic loads, the globally attracting point is the trivial equilibrium Q = 0, that is, zero β-cell mass. The decrease in the stable equilibrium value with increasing glycemic load is due to an increased β-cell death rate at such high loads, both as a result of higher glucose toxicity (Efanova et al., 1998) , and of increased susceptibility to apoptosis at higher insulin levels (Johnson and Alejandro, 2008) ; the latter authors describe this situation as a "sweet spot" for insulin in the high pico-molar range, which corresponds to order 1 levels in the scaled system.
As might be expected from the strong separation of time scales, the approximation for the slowtime scale dynamics is excellent. Figure 4 compares the dynamics according to the approximation (which is simple and 1-dimensional) to the dynamics of the original, 7-dimensional, system, in an overfeeding and an underfeeding simulation. The results are indistinguishable: thus, the long-term dynamics is well-captured by the approximation. The full system was numerically integrated in fast time using an explicit Runge-Kutta method of order 2(1), which is the Mathematica default method (Sofroniou and Spaletta, 2004) . The slow system was evaluated using Euler-forward with a step size of one day, giving virtually the same result at less than a thousandth of the computational cost (run time; excluding the one-time cost of establishing the dynamics of x 7 , which costs about 1% of the full-system's run time).
In formulating a mathematical model for the long-term dynamics of the β-cell mass, it is tempting, although incorrect, to represent the glycemic load as a constant that represents the average of the daily cycle (e.g., Topp et al., 2000; De Winter et al., 2006; Ribbing et al., 2010) . However, the dynamics of x [1] 7 in slow time τ do in fact depend critically on the "temporal fine structure" of glucose uptake on the fast time scale t, through the integration in equation (12). Such dependence is neglected by an approach that replaces glucose uptake by its short-term average. This becomes readily apparent when we consider the case where the glycemic load is assimilated as a constant infusion (set to zero for the first 30 minutes after midnight, to enforce a 24-hour cycle) instead of a daily 3-meal cycle. It is found that the long-term dynamics of the β-cell mass is strikingly different: the "pathological fixed point" remains very close to zero and the system achieves near-perfect regulation of the average glucose level even at a hyperglycemic load that is 4 time higher than normal, as shown in Figure 5 . Comparison with the case ι ai → ∞ (not shown) shows that decrease of insulin's potency in inhibiting apoptosis at high levels is responsible for keeping the β-mass in check without compromising the ability to regulate: for ι ai → ∞, the fixed point of x 7 increases sharply with load, even though normalisation of glucose levels is already achieved at x 7 -values comparable to those indicated in Figure 5 .
Extended model with neogenesis of β-cells
The response dynamics shown in Figure 4 is very slow. An example of such sluggish dynamics is shown in Figure 6 : if 80% of the β-cell mass is destroyed, it takes about 50 years to recover. This means that the subject will be effectively diabetic for much of his or her lifetime; the baseline turn-over dynamics of β-cells is too sluggish to respond adequately to such challenges. However, in reality, recovery from such damage is accomplished within a few weeks' time (Bouwens and Rooman, 2005) . It has been proposed that the slowly proliferating β-cell pool may, under certain conditions, be replenished by differentiation of cells from a more quickly proliferating pool of progenitor cells (De León et al., 2003; Rooman et al., 2002) that is phenotypically distinct from the differentiated β-cells themselves (Ackermann Misfeldt et al., 2008) . A competing hypothesis is that β-cells themselves are capable of rapid proliferation (Dor et al., 2004; Lee et al., 2006; Nir et al., 2007) . The two hypotheses may be reconciled if the rapidly proliferating pool of cells is derived (by a process akin to dedifferentiation) from adult β-cells, since such cells are readily driven back into cell cycle by activation of the proto-oncogene c-myc (Pelengaris et al., 2002) . Here, the pool of proliferators will be treated as a source term, an approach compatible with either point of view. We shall refer, for the sake of clarity, to the proliferator pool as "progenitors", with the caveat noted above. We propose to describe the neogenesis of β-cells from progenitor cells by the following equation:
with positive parameters ψ ng , α ng,g , α ng,i , ι ng , and γ ng . This equation is built from the same generic sigmoid building blocks used in the orginal model, to represent graded responses to the relevant stimuli. The key assumption is that neogenesis is driven by prolonged hyperglycemia (Lipsett and Finegood, 2002) in conjunction with elevated insulin levels (Grossman et al., 2010) . It may be observed that the right-hand side of equation (20) behaves like a soft and-gate: the flux ψ ng is large when both glucose and insulin levels are elevated. Prolonged concurrence of high glucose and insulin levels may be associated with insufficiency, so it would make teleological sense, in a manner of speaking, to control β-cell mass compensation in this manner. From a mechanistic point of view, it is known that the pathway regulating rapid β-cell proliferation can act like an andgate. Specifically, the proto-oncogene gene c-myc, which encodes the transcription factor c-Myc, which stimulates proliferation as well as susceptibility to apoptosis (Pelengaris and Khan, 2003) such that the net effect is loss of β-cells unless an anti-apoptotic co-signal is present (Pelengaris et al., 2002) . Expression of c-Myc is induced by glucose ) whereas insulin induces an anti-apoptotic signal (Johnson et al., 2006) . Thus, whereas glucose alone induces a net loss of β-cells ( Van de Casteele et al., 2003) , the simultaneous presence of glucose and insulin would stimulate rapid proliferation, possibly via rapid (partial) dedifferentiation of existing adult β-cells to the proliferative phenotype. It has been suggested that this dual proliferation/apoptosis pathway acting via c-myc acts as a fail-safe that defaults to β-cell loss unless both glucose and insulin are elevated (Pelengaris and Khan, 2003) . The action of glucose is indirect and thought to be via glucagon-like peptide 1 (GLP-1; De León et al., 2003) , an incretin and cytokine which is secreted by enteroendocrine L-cells. Since the halflife of GLP-1 is extremely short (Mentlein et al., 1993) , an instantaneous functional dependence on G/V p appears warranted. In principle, ψ ng should also depend on, and be limited by, the amount of progenitor cells present in the pancreas; in the present model, this pool is assumed to be non-limiting and is thought of as an unlimited source. When neogenesis is included in the model, recovery from partial ablation of β-cell mass is much more rapid and in keeping with the various values quoted in the literature (recovery in a 1 to 5 week period; see Bouwens and Rooman, 2005 , for a review of the experimental data), as shown in Figure 7 . The slow-time approximation is still excellent, despite the fact that time-scale separation is now up to two orders of magnitude worse due to the rapid β-cell expansion that occurs when the β-cell mass is too low. The relationship between d dτ x 7 and x 7 remains qualitatively the same, except that the lower, unstable fixed point (the pathological fixed point) is now very low and the positive rate of change that prevails when x 7 lies in between the fixed points is now several orders of magnitude larger.
If too much of the β-cell mass is destroyed, recovery takes disproportionally longer, as shown in the bottom panel of Figure 7 : when more than ∼ 80% of the β-cells are destroyed, recovery takes the best part of a year, which implies the subject is diabetic for a number of months until recovery occurs.
Type 1 diabetes is an illness due to autoimmunity directed against β-cells (Watkins, 2003) . The simulations in Figure 7 suggest that there is a critical level of ablation at which recovery becomes very much slower. If the progenitor cells do not express the insulin-derived antigen, or do so in sufficiently low levels to escape immune attack, the progression to type 1 diabetes is a matter of ψ ng being unable to compensate for the losses, leading to a net diminishment of β-cell mass until the critical depletion level is reached. If the progenitor cells are also susceptible to immune attack, the rate of recovery will be further compromised and the rate at which the β-cell mass descends to the critical level may be accelerated.
Discussion
The interplay between the glycemic homeostasis feedback loop, which operates on the ultradian time scale, and the adaptive changes in β-cell mass, which happen on a days-to-months time scale, is a typical feature of endocrinological and neuroendocrinological regulation, where a slower adaptive feedback loop is superimposed on a more rapid feedback loop, the latter directly involved with a physiological system, with the former regulating the level of activity in some manner, e.g. by controlling rates of transcription, translation, electrical activity (secretion), or, as in the present example, number of endocrine cells (Brook and Marshall, 2001) . Moreover, the dynamics of such systems usually exhibits a strongly non-linear character (Keener and Sneyd, 1998) , which means that small variations in the precise time courses of the fast processes (the temporal fine structure) can have a profound effect on the rates of change of the slow processes. Time-scale separation can be a powerful tool to abstract a low-dimensional dynamical system modelling the slow adaptation process, which is considerably more easy to analyse and visualise. In the present case, a 7-dimensional dynamics is reduced to 1-dimensional dynamics, which is straightforward to analyse; indeed, as Figure 3 shows, in qualitative terms the system is much like logistic growth with an Allee effect.
When equation (12) is evaluated (in most cases this needs to be done numerically), the causal relationships may be obscured somewhat. For instance, in the present model, the rate of change of the β-mass is dependent, in the direct, mechanistic sense of the word, on glucose and insulin, as the model's equations make explicit. However, the time courses of glucose and insulin depend on the prevailing β-cell mass, together with the input ψ in , and as a result, in slow time, the rate of change of the β-cell mass depends on the β-cell mass itself plus the input waveform, i.e., the rate of change in slow time is a functional of the input ψ in (t), as is clear from the integration over the fast-time scale cycle in equation (12) . In this way, the temporal fine structure is taken into account, in analogy to similar spatial homogenisation procedures (see Keener and Sneyd, 1998, and Holmes, 1995) .
The assumption in this paper has been that rapid compensation in β-cell mass is driven by proliferation, based on the observation that β-cells can be driven back into cell cycle by activation of c-myc (Pelengaris et al., 2002) and data on recovery from partial pancreatomy and hyperglycemic challenge (Bouwens and Rooman, 2005) . However, it is also possible that β-cells respond by adjusting the amount of hormone-producting machinery per cell (and, concomitantly, cell volume) and that data concerning short-term changes in numbers of β-cells are distorted by the fact that temporarily depleted cells (degranulated cells) are spuriously not counted as β-cells (Akirav et al., 2008) . The relative importance of such non-proliferative adaptation, which possibly depends on the time scales and extend of challenge at hand, remains to be elucidated in detail; whereas hypertrophy was held to be the main mechanism for increases in β-cell mass in man until the last decade (Nielsen et al., 1999; Weir et al., 2001) , recent years have seen a change in emphasis towards proliferation and neogenesis (Bouwens and Rooman, 2005; Lingohr et al., 2002; Pelengaris et al., 2002) .
In the model considered here, all but one of the state variables was fast. The Sturis-Tolić model can be extended with further slow variables. One such variable might be the insulin sensitivity of the body's tissues, which plays a major role in the etiology of type 2 diabetes (Salway, 1999) . However, a more precise characterisation of the process we have referred to as neogenesis is essential to make progress: in particular, the maximum rate at which this pool can proliferate, as well as the rates at which it is replenished (which may depend on the sources: β-cells are transdifferentiated pancreatic cells) are likely to be critical to the ability of neogenesis to furnish the amount of new β-cells required. The present paper has shown that the pathological fixed point, first noted and so termed by Topp et al. (2000) , becomes a prominent factor only when neogenesis is impaired, and, moreover, that this pathological fixed point has a value that is dependent on the diel time course of the rate at which glucose is administered to the system. Whereas mathematical modelling can never replace the experiments that elucidate these processes, it can help to characterise the functional consequences of these findings along the lines outlined in the present paper. first pivot point of β-cell death rate γ 2 2.6 g l with positive parameters µ, α 1 , α 2 , γ 1 , and γ 2 . The above formulas and the values listed in Table 1 have been taken from Tolić et al. (2000) , with the addition of two novel elements: glucose excretion (ψ gx ), which is necessary to represent hyperglycaemic challenges, and the β-cell mass dynamics. Glucose excretion is based on the graph given in Schmidt and Thews (1989) , whereas β-cell mass dynamics is based on various data from the literature, as detailed in Appendix B. obtain reasonable values for the relevant parameters (those with subscript ng), simulations were performed that mimicked an experiment described by Steil et al. (2001) in which rats were given infusions of glucose that initially doubled the plasma glucose levels. Within a day, euglycemia was re-established and the β-cell mass had doubled. The simulations are shown in Figure B .10
